Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −2 vs. Q4 2024
- Shares held
- 1.02M
- +619.0K (+153.2%) vs. Q4 2024
- Total value
- $1.09M
- +$530.8K (+94.7%) vs. Q4 2024
- New holders
- 4
- 7 more added
- Sold out
- 6
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 690,666 | $870.2K | 0.02% | +690,666 | New |
| Geode Capital Management, LLC | 58,165 | $73.3K | 0.00% | +5,664+10.8% | Added |
| Vanguard Group Inc | 27,724 | $34.9K | 0.00% | −50,717−64.7% | Reduced |
| BlackRock, Inc. | 25,172 | $31.7K | 0.00% | 00.0% | Unchanged |
| Liberty Wealth Management LLC | 22,666 | $28.6K | 0.01% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 16,153 | $20.4K | 0.00% | +4,853+42.9% | Added |
| Weaver Consulting Group | 15,623 | $19.7K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 4,338 | $5.47K | 0.00% | +21+0.5% | Added |
| Advisor Group Holdings, Inc. | 1,719 | $2.16K | 0.00% | −196−10.2% | Reduced |
| Wells Fargo & Company | 1,338 | $1.69K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 334 | $421 | 0.00% | 00.0% | Unchanged |
| Bangor Savings Bank | 266 | $335 | 0.00% | +266 | New |
| UBS Group AG | 253 | $319 | 0.00% | −3,219−92.7% | Reduced |
| FMR LLC | 233 | $294 | 0.00% | +122+109.9% | Added |
| SBI Securities Co., Ltd. | 220 | $277 | 0.00% | +53+31.7% | Added |
| Jones Financial Companies LLLP | 216 | $257 | 0.00% | +216 | New |
| JPMorgan Chase & Co | 171 | $215 | 0.00% | +166+3,320.0% | Added |
| Tower Research Capital LLC (TRC) | 135 | $170 | 0.00% | +135 | New |
| VSM Wealth Advisory, LLC | 120 | $151 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 113 | $142 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 111 | $140 | 0.00% | +5+4.7% | Added |
| Clearstead Advisors, LLC | 100 | $126 | 0.00% | 00.0% | Unchanged |
| Cranbrook Wealth Management, LLC | 66 | $84 | 0.00% | 00.0% | Unchanged |
| St Germain D J Co Inc | 33 | $42 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 24 | $30 | 0.00% | 00.0% | Unchanged |
| Centricity Wealth Management, LLC | 20 | $25 | 0.00% | 00.0% | Unchanged |
| CBIZ Investment Advisory Services, LLC | 13 | $16 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 12 | $16 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 10 | $13 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 8 | $10 | 0.00% | 00.0% | Unchanged |
| Bogart Wealth, LLC | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 157,009 | $0 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −20,022−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −6,016−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,971−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −747−100.0% | Sold out |
| Transce3nd, LLC | 0 | $0 | 0.00% | −148−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −141−100.0% | Sold out |